S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Laser breakthrough could send stock soaring 2,476% (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Laser breakthrough could send stock soaring 2,476% (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Laser breakthrough could send stock soaring 2,476% (Ad)
Daqo New Energy Charged Up For New Highs
TG Therapeutics Stock 300% Rally Has Legs Yet
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Laser breakthrough could send stock soaring 2,476% (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Laser breakthrough could send stock soaring 2,476% (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Laser breakthrough could send stock soaring 2,476% (Ad)
Daqo New Energy Charged Up For New Highs
TG Therapeutics Stock 300% Rally Has Legs Yet
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Laser breakthrough could send stock soaring 2,476% (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Laser breakthrough could send stock soaring 2,476% (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Laser breakthrough could send stock soaring 2,476% (Ad)
Daqo New Energy Charged Up For New Highs
TG Therapeutics Stock 300% Rally Has Legs Yet
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Laser breakthrough could send stock soaring 2,476% (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Laser breakthrough could send stock soaring 2,476% (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Laser breakthrough could send stock soaring 2,476% (Ad)
Daqo New Energy Charged Up For New Highs
TG Therapeutics Stock 300% Rally Has Legs Yet
NASDAQ:HOLX

Hologic - HOLX Stock Forecast, Price & News

$85.61
-0.55 (-0.64%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$85.28
$86.65
50-Day Range
$73.31
$86.16
52-Week Range
$59.78
$86.65
Volume
1.54 million shs
Average Volume
1.97 million shs
Market Capitalization
$21.11 billion
P/E Ratio
21.84
Dividend Yield
N/A
Price Target
$84.08

Hologic MarketRank™ Forecast

Analyst Rating
Hold
2.47 Rating Score
Upside/​Downside
1.8% Downside
$84.08 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.05
Upright™ Environmental Score
News Sentiment
0.56mentions of Hologic in the last 14 days
Based on 43 Articles This Week
Insider Trading
Selling Shares
$2.05 M Sold Last Quarter
Proj. Earnings Growth
6.68%
From $3.74 to $3.99 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

290th out of 1,026 stocks

X - Ray Apparatus & Tubes Industry

1st out of 4 stocks

HOLX stock logo

About Hologic (NASDAQ:HOLX) Stock

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment consists of products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Stock News Headlines

QIAGEN's (QGEN) Q4 Earnings Top Estimates, Margins Down
New Years, New Ways To Trade!
If you’ve been considering options trading but don’t know where to start, trading champion Chuck Hughes’ coveted guide, “Options Trading Made Easy” is for you! Free for a limited time, this guide could help 2023 become your most profitable year yet! Click here for a free copy now! pixel
Cowen Boosts Hologic (NASDAQ:HOLX) Price Target to $95.00
Hologic (NASDAQ:HOLX) PT Raised to $93.00
Raymond James Boosts Hologic (NASDAQ:HOLX) Price Target to $95.00
New Years, New Ways To Trade!
If you’ve been considering options trading but don’t know where to start, trading champion Chuck Hughes’ coveted guide, “Options Trading Made Easy” is for you! Free for a limited time, this guide could help 2023 become your most profitable year yet! Click here for a free copy now! pixel
McKesson (MCK) Q3 Earnings Surpass Estimates, EPS View Up
Hologic Deserves To Trade A High Earnings Multiple
Hologic (HOLX) Scheduled to Post Quarterly Earnings on Wednesday
Hologic (HOLX) Stock Moves -0.2%: What You Should Know
In Search of an Earnings Beat? Play These Top 5 Stocks
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Company Calendar

Last Earnings
2/01/2023
Today
2/08/2023
Next Earnings (Estimated)
4/26/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
Employees
6,944
Year Founded
1985

Price Target and Rating

Average Stock Price Forecast
$84.08
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
-1.8%
Consensus Rating
Hold
Rating Score (0-4)
2.47
Research Coverage
15 Analysts

Profitability

Net Income
$1.30 billion
Pretax Margin
26.99%

Debt

Sales & Book Value

Annual Sales
$4.86 billion
Cash Flow
$7.96 per share
Book Value
$20.66 per share

Miscellaneous

Free Float
242,461,000
Market Cap
$21.11 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Stephen P. MacMillanStephen P. MacMillan
    Chairman, President & Chief Executive Officer
  • Karleen Marie Oberton
    Chief Financial Officer
  • Paul Malenchini
    Chief Information Officer
  • Monica Aguirre Berthelot
    Chief of Staff, Vice President
  • Marci J. Lerner
    Vice President & Treasurer













HOLX Stock - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings
or view top-rated stocks.

What is Hologic's stock price forecast for 2023?

15 Wall Street research analysts have issued 1 year price objectives for Hologic's stock. Their HOLX share price forecasts range from $70.00 to $95.00. On average, they expect the company's share price to reach $84.08 in the next twelve months. This suggests that the stock has a possible downside of 1.8%.
View analysts price targets for HOLX
or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2023?

Hologic's stock was trading at $74.81 at the beginning of 2023. Since then, HOLX shares have increased by 14.4% and is now trading at $85.61.
View the best growth stocks for 2023 here
.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our HOLX earnings forecast
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) announced its earnings results on Wednesday, February, 1st. The medical equipment provider reported $1.07 EPS for the quarter, beating the consensus estimate of $0.90 by $0.17. The medical equipment provider earned $1.07 billion during the quarter, compared to analysts' expectations of $1.01 billion. Hologic had a net margin of 22.17% and a trailing twelve-month return on equity of 25.12%. Hologic's quarterly revenue was down 27.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.17 earnings per share.
Read the conference call transcript
.

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its FY23 earnings guidance on Wednesday, February, 1st. The company provided earnings per share guidance of $3.55-$3.85 for the period, compared to the consensus estimate of $3.56. The company issued revenue guidance of $3.85-$4.00 billion, compared to the consensus revenue estimate of $3.90 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Parnassus Investments LLC (1.54%), TD Asset Management Inc (0.80%), California Public Employees Retirement System (0.57%), Nordea Investment Management AB (0.56%), DekaBank Deutsche Girozentrale (0.53%) and Sumitomo Mitsui Trust Holdings Inc. (0.44%). Insiders that own company stock include Benjamin Jordan Cohn, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends
.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $85.61.

How much money does Hologic make?

Hologic (NASDAQ:HOLX) has a market capitalization of $21.11 billion and generates $4.86 billion in revenue each year. The medical equipment provider earns $1.30 billion in net income (profit) each year or $3.92 on an earnings per share basis.

How many employees does Hologic have?

The company employs 6,944 workers across the globe.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The official website for the company is www.hologic.com. The medical equipment provider can be reached via phone at (508) 263-2900, via email at michael.watts@hologic.com, or via fax at 781-890-8031.

This page (NASDAQ:HOLX) was last updated on 2/9/2023 by MarketBeat.com Staff